Evidence map›Paper›PMID 35420469›Full record

ArticlemBio2022

The Delta SARS-CoV-2 Variant of Concern Induces Distinct Pathogenic Patterns of Respiratory Disease in K18-hACE2 Transgenic Mice Compared to the Ancestral Strain from Wuhan.

Xiang Liu, Helen Mostafavi, Wern Hann Ng, Joseph R Freitas, Nicholas J C King, Ali Zaid, Adam Taylor, Suresh Mahalingam

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in mBio, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05711810 (Cardiac Transfer of SARS-CoV-2 Spike Protein Circulation Techniques - Medicine Induced Hemodialysis on "Vaccinated" Immune Attacks), which is not on this map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05711810 phase4completednot on this mapstarted 2023, after this paper: background citation

Cardiac Transfer of SARS-CoV-2 Spike Protein Circulation Techniques - Medicine Induced Hemodialysis on "Vaccinated" Immune Attacks

TypeinterventionalSponsorYang I. PachankisRan2023 to 2023Enrolled1ConditionsSevere Acute Respiratory Syndrome-related Coronavirus, Renal Dialysis, Vaccines, Myocarditis AllergicArmsNifedipine 30 MG, Kangzhu BPCB0A-3A, Low Mobility, Enalapril Maleate 10Mg Tab, Lansoprazole 30Mg Ec Cap
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Initial immune response after exposure toFrontiers in immunology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Xiang LiuMenzies Health Institute Queensland, Griffith Universitygrid.1022.1, Gold Coast, Queensland, Australia.ORCID 0000-0002-8165-3294
Helen MostafaviMenzies Health Institute Queensland, Griffith Universitygrid.1022.1, Gold Coast, Queensland, Australia.ORCID 0000-0002-6051-3268
Wern Hann NgMenzies Health Institute Queensland, Griffith Universitygrid.1022.1, Gold Coast, Queensland, Australia.ORCID 0000-0001-8438-7203
Joseph R FreitasMenzies Health Institute Queensland, Griffith Universitygrid.1022.1, Gold Coast, Queensland, Australia.
Nicholas J C KingMenzies Health Institute Queensland, Griffith Universitygrid.1022.1, Gold Coast, Queensland, Australia.ORCID 0000-0002-3877-9772
Ali Zaid *Menzies Health Institute Queensland, Griffith Universitygrid.1022.1, Gold Coast, Queensland, Australia.ORCID 0000-0002-2528-2783
Adam Taylor *Menzies Health Institute Queensland, Griffith Universitygrid.1022.1, Gold Coast, Queensland, Australia.ORCID 0000-0002-7159-3961
Suresh Mahalingam *Menzies Health Institute Queensland, Griffith Universitygrid.1022.1, Gold Coast, Queensland, Australia.ORCID 0000-0003-3141-8410
Griffith University · AU

Funding

Department of Health | National Health and Medical Research Council (NHMRC) 1154347
6 · The paper itself

Abstract

Compared to the original ancestral strain of SARS-CoV-2, the Delta variant of concern has shown increased transmissibility and resistance toward COVID-19 vaccines and therapies. However, the pathogenesis of the disease associated with Delta is still not clear. In this study, using K18-hACE2 transgenic mice, we assessed the pathogenicity of the Delta variant by characterizing the immune response following infection. We found that Delta induced the same clinical disease manifestations as the ancestral SARS-CoV-2, but with significant dissemination to multiple tissues, such as brain, intestine, and kidney. Histopathological analysis showed that tissue pathology and cell infiltration in the lungs of Delta-infected mice were the same as in mice infected with the ancestral SARS-CoV-2. Delta infection caused perivascular inflammation in the brain and intestinal wall thinning in K18-hACE2 transgenic mice. Increased cell infiltration in the kidney was observed in both ancestral strain- and Delta-infected mice, with no clear visible tissue damage identified in either group. Interestingly, compared with mice infected with the ancestral strain, the numbers of CD45

Indexed as

COVID-19 Drug TreatmentHepatitis DAnimalsCOVID-19 VaccinesDisease Models, Animalgamma-GlobulinsHumansMelphalanMiceMice, TransgenicPandemicsSARS-CoV-2COVID-19 Vaccinesgamma-GlobulinsK-18 conjugateMelphalancoronavirusDelta variantmouse modelSARS-CoV-2

Identifiers

PMID35420469
PMCPMC9239116
OpenAlexW4223902721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.